{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "AstraZeneca, Gaithersburg, MD, USA",
    "3Division of Breast Surgery, Department of Surgery, Brigham and Women’s Hospital, Boston, MA, USA",
    "Brigham and Women’s Hospital, Boston, MA, USA",
    "9Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC, USA",
    "3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA",
    "2Harvard Medical School, Boston, MA, USA",
    "5Georgetown University, Washington, DC, USA",
    "6MedStar Georgetown University Hospital, Washington, DC, USA",
    "8University of Utah, Salt Lake City, UT, USA",
    "4Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA",
    "Department of Surgery, Harvard Medical School, Boston, MA, USA",
    "Ludwig Center for Cancer Research at Harvard, Harvard Medical School, Boston, MA, USA",
    "University of North Carolina at Chapel Hill, Chapel Hill, NC, USA",
    "Harvard University/Brigham and Women’s Hospital, Boston, MA, USA",
    "Harvard Medical School, Boston, MA, USA",
    "The University of Texas MD Anderson Cancer Center, Houston, TX, USA",
    "Atrium Health, Charlotte, NC, USA",
    "Dana Farber Cancer Institute, Boston, MA, USA",
    "Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 23,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Julie Collins"
    },
    {
      "affs": [
        1
      ],
      "name": "Anita Mehta"
    },
    {
      "affs": [
        2
      ],
      "name": "Adam Nelson"
    },
    {
      "affs": [
        3
      ],
      "name": "Claudine Isaacs"
    },
    {
      "affs": [
        4
      ],
      "name": "Filipa Lynce"
    },
    {
      "affs": [
        5
      ],
      "name": "Kenichi Shimada"
    },
    {
      "affs": [
        6
      ],
      "name": "Xue Geng"
    },
    {
      "affs": [
        7
      ],
      "name": "Candace Mainor"
    },
    {
      "affs": [
        8
      ],
      "name": "Mei Wei"
    },
    {
      "affs": [
        6
      ],
      "name": "Hongkun Wang"
    },
    {
      "affs": [
        9
      ],
      "name": "Kiran Kurmi"
    },
    {
      "affs": [
        2
      ],
      "name": "Carlos Wagner S Wanderley"
    },
    {
      "affs": [
        10
      ],
      "name": "Daniel E Michaud"
    },
    {
      "affs": [
        11
      ],
      "name": "Jennifer L Guerriero"
    },
    {
      "affs": [
        12
      ],
      "name": "Jessica E Thaxton"
    },
    {
      "affs": [
        13
      ],
      "name": "Alexander P Gottlieb"
    },
    {
      "affs": [
        14
      ],
      "name": "Gabriella Antonellis"
    },
    {
      "affs": [
        2
      ],
      "name": "Kelly F Zheng"
    },
    {
      "affs": [
        2
      ],
      "name": "Madeline G Townsend"
    },
    {
      "affs": [
        15
      ],
      "name": "Paula R Pohlmann"
    },
    {
      "affs": [
        16
      ],
      "name": "Arielle L Keeke"
    },
    {
      "affs": [
        17
      ],
      "name": "Geoffrey I Shapiro"
    },
    {
      "affs": [
        18
      ],
      "name": "Marcia C Haigis"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/78npaefxxcmk8.bib",
  "cited_by": 0,
  "doi": "10.1136/jitc-2026-sitc2026.0837",
  "fulltext_url": null,
  "id": "78npaefxxcmk8",
  "issns": [
    "2051-1426"
  ],
  "landing_url": "https://doi.org/10.1136/jitc-2026-sitc2026.0837",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "RC254-282"
    ],
    [
      "openalex",
      "2730|PARP inhibition in cancer therapy"
    ]
  ],
  "openalex": "W7225181756",
  "pdf_url": "https://jitc.bmj.com/content/14/Suppl_2/A949.full.pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-06",
  "publisher": "BMJ Publishing Group",
  "ris": "https://research.draconitic.com/paper/78npaefxxcmk8.ris",
  "sources": [
    {
      "first_seen": "2026-11-07T14:21:06Z",
      "native_id": "19e690e098164b1aa8dec0caf6b1d3c1",
      "source": "doaj",
      "url": "https://doi.org/10.1136/jitc-2026-sitc2026.0837"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2730|PARP inhibition in cancer therapy",
      "subfield": "oncology"
    }
  ],
  "title": "837 Targeting a CD36-dependent macrophage immunometabolic program enhances PARP inhibitor response in BRCA-associated TNBC",
  "title_text": "837 Targeting a CD36-dependent macrophage immunometabolic program enhances PARP inhibitor response in BRCA-associated TNBC",
  "type": "peer-reviewed",
  "updated_at": "2026-11-08T14:20:33Z",
  "url": "https://research.draconitic.com/paper/78npaefxxcmk8",
  "venue": "Journal for ImmunoTherapy of Cancer",
  "versions": []
}